Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio (Q39014551)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2014

Language	Label	Description	Also known as
English	Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio	scientific article published on June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

apoptotic process

0 references

author name string

Neetu Singh

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jayanta Sarkar

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Koneni V Sashidhara

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Shakir Ali

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sudhir Sinha

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

1 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1017-1028

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cytotoxic chemotherapy for advanced or recurrent cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Cancer cells acquire resistance to anticancer drugs: an update

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Coumarins: old compounds with novel promising therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Exploring pharmacological significance of chalcone scaffold: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Anti-breast cancer activity of heteroaryl chalcone derivatives

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative Disorders and Beyond

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Antiproliferative action of Xylopia aethiopica fruit extract on human cervical cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Requirement of MTA1 in ATR-mediated DNA damage checkpoint function

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Recent advances in understanding the cell death pathways activated by anticancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Upregulation of DR5 receptor by the diaminothiazole DAT1 [4-amino-5-benzoyl-2-(4-methoxy phenyl amino) thiazole] triggers an independent extrinsic pathway of apoptosis in colon cancer cells with compromised pro and antiapoptotic proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Molecular characterization of mitochondrial apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

BCL-2 family antagonists for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

A unified model of mammalian BCL-2 protein family interactions at the mitochondria.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Apoptosis and cancer: the genesis of a research field

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Deconstructing p53 transcriptional networks in tumor suppression

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

PUMA, a potent killer with or without p53

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Chalcone-imidazolone conjugates induce apoptosis through DNA damage pathway by affecting telomeres

1 reference

https://api.crossref.org/works/10.1007%2FS10495-014-0975-2

21 January 2018

Identifiers

10.1007/S10495-014-0975-2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39014551&oldid=2226011622"